Skip to main content
. 2007 Feb 15;2:7. doi: 10.1186/1748-717X-2-7

Table 8.

Results from dose plan analysis for Patient 4

Obj Corvus1 Eclipse1 Hyperion2 KonRad1 OMP2 PinnEUD2 PinnPhy2 Precise2
PTV1 (18 Gy)
Maxpt Gy Prescript 21.0 20.0 21.4 22.5 21.7 23.9 21.0 23.6
D1% Gy Prescript 20.0 19.5 20.4 21.6 19.8 21.7 19.6 21.4
D99% Gy Prescript 15.2 14.2 11.8 12.9 16.2 14.5 16.2 14.3
V90% % 100% 96.8 96.7 91.9 95.2 99.0 97.4 99.0 97.6
V107% % 0% 7.3 2.4 14.6 18.5 3.8 13.8 2.2 12.7
SD Gy 0 Gy 0.9 0.9 1.5 1.5 0.7 1.2 0.6 1.2
CI 1.0 1.53 1.12 1.11 1.30 1.28 1.16 1.27 1.31

Kidney
Mean Gy < 10 Gy 7.7 5.1 6.4 8.0 9.3 7.7 9.7 9.3
Max pt Gy Minimise 17.5 13.4 12.2 13.4 18.1 13.7 17.3 14.1
D1% Gy Minimise 14.8 12.0 11.3 12.5 16.7 12.7 16.0 13.4
V5 Gy % Minimise 78.6 39.7 72.2 97.2 98.0 87.8 97.3 98.1
Healthy tissue
Mean Gy Minimise 8.8 6.1 7.0 7.9 8.2 7.1 7.6 7.0
Max pt Gy Minimise 20.5 19.7 17.7 22.6 21.6 20.6 20.6 23.1
V10 Gy cm3 Minimise 1920 970 1200 1580 1650 1380 1600 1300
nV10 Gy Minimise 1.9 0.8 0.9 1.3 1.4 1.1 1.3 1.1
V90% cm3 Minimise 561 206 219 440 339 227 331 348

1: TPS belonging to the first family type

2: TPS belonging to the second family type